Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medbright AI Investments Inc MBAIF


Primary Symbol: C.MBAI

MedBright AI Investments Inc. is a capital allocator focused on investing in healthcare technology companies. The Company is engaged in constructing a portfolio of synergistic investments to generate returns for shareholders. The Company is focused on significant near-term and midterm opportunities with potential returns while maintaining a commitment to governance. It is focused on investing in technology and artificial intelligence companies, combined with healthcare operators.


CSE:MBAI - Post by User

Post by MarketMakersson Feb 01, 2024 6:02pm
25 Views
Post# 35858266

Targeting the $200 Billion Healthcare Problem

Targeting the $200 Billion Healthcare Problem
Highlighting the substantial scalability of its technology and the vast addressable market it offers, MedBright AI (MBAI.c MBAIF) recently expanded its utilization of MedMatrix, an AI-powered data analytics platform.
 
Rejuvenation, a prominent dermatology group and leader in advanced dermatological care, is expanding its already established use of MedMatrix to include marketing for cosmetic treatments and clinical trial recruitment and data analysis.
 
Rejuvenation's extensive network includes 8 clinics spread across 3 provinces with a highly skilled team comprising 21 dermatologists, 5 Mohs surgeons, 2 plastic surgeons, and 13 general practitioners specializing in dermatology.
 
Despite having a mcap of only $22M, MBAI has expanded to 14 clinics, including a Yale University-Affiliated Clinic, and is strongly positioned to fix the $200 billion healthcare problem of congested waiting rooms.
 
As MBAI continues to execute on this path, it could mean quick multiples from successfully solving even a small percentage of the addressable market.
 
MedMatrix
Focused on the intersection of healthcare and technology to match patient needs with enhanced revenue opportunities, MedBright AI (MBAI.c MBAIF) is the primary shareholder of and is targeting the healthcare waiting room problem with MedMatrix.
 
As detailed in this short introduction video, MedMatrix is an AI-powered data analytics platform and engine that analyzes crucial aspects of healthcare facilities and work alongside healthcare professionals to drastically improve healthcare operations and enhance clinic revenue by 10% at no additional cost to the clinic: https://youtu.be/f3bcx2T_GzQ?si=9CXluAYD43PEDMM9
 
In better aligning physician resources with patient needs, MedMatrix evaluates numerous factors related to a patients background, clinical interaction history and other factors to predict the resource needs for their upcoming visits and optimize provider schedules, without the need for a new platform or additional training.
 
 
Posted on Behalf of MedBright AI Investments Inc.

<< Previous
Bullboard Posts
Next >>